We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
DHI Group
DHX
$166M
| $492K | ﹤0.01% |
258,994
-12,800
| -5% | -$26.5K |
|
1777
NWPX Infrastructure Inc
NWPX
$1.25B
| $492K | ﹤0.01% |
25,704
-11,700
| -31% | -$217K |
|
|
RXDX
1778
DELISTED
Ignyta, Inc.
RXDX
| $491K | ﹤0.01% |
18,400
-6,500
| -26% | -$106K |
|
1779
Sixth Street Specialty
TSLX
$1.59B
| $488K | ﹤0.01% |
24,624
-97,700
| -80% | -$2M |
|
|
AMBR
1780
DELISTED
Amber Road Inc
AMBR
| $482K | ﹤0.01% |
65,702
-12,400
| -16% | -$92.6K |
|
|
EOCC
1781
DELISTED
Enel Generacion Chile S.A.
EOCC
| $482K | ﹤0.01% |
17,900
-28,200
| -61% | -$737K |
|
1782
Honda
HMC
$36.5B
| $481K | ﹤0.01% |
+14,100
| New | +$456K |
|
1783
Miller Industries
MLR
$586M
| $476K | ﹤0.01% |
18,452
-500
| -3% | -$13.5K |
|
1784
PDF Solutions
PDFS
$2.13B
| $476K | ﹤0.01% |
30,300
+11,800
| +64% | +$190K |
|
1785
uniQure
QURE
$2.68B
| $476K | ﹤0.01% |
+24,300
| New | +$370K |
|
1786
WSFS Financial
WSFS
$4.1B
| $474K | ﹤0.01% |
9,900
-5,403
| -35% | -$266K |
|
|
BRKL
1787
DELISTED
Brookline Bancorp
BRKL
| $473K | ﹤0.01% |
30,138
-6,400
| -18% | -$99.8K |
|
|
CBB
1788
DELISTED
Cincinnati Bell Inc.
CBB
| $467K | ﹤0.01% |
22,385
+7,500
| +50% | +$152K |
|
1789
BioCryst Pharmaceuticals
BCRX
$2.37B
| $464K | ﹤0.01% |
94,400
+8,900
| +10% | +$43.1K |
|
|
XOMA
1790
DELISTED
Xoma
XOMA
| $464K | ﹤0.01% |
+13,020
| New | +$353K |
|
|
CTRL
1791
DELISTED
Control4 Corporation
CTRL
| $464K | ﹤0.01% |
15,600
-47,100
| -75% | -$1.46M |
|
1792
Mitek Systems
MITK
$762M
| $461K | ﹤0.01% |
+51,503
| New | +$470K |
|
|
MCBC
1793
DELISTED
Macatawa Bank Corp
MCBC
| $461K | ﹤0.01% |
46,100
+5,000
| +12% | +$50.4K |
|
|
CNH
1794
CNH Industrial
CNH
$13.8B
| $459K | ﹤0.01% |
39,367
+1,149
| +3% | +$12.7K |
|
|
SNBC
1795
DELISTED
Sun Bancorp Inc
SNBC
| $458K | ﹤0.01% |
18,829
+3,400
| +22% | +$85.2K |
|
1796
Kemper
KMPR
$1.7B
| $457K | ﹤0.01% |
6,626
-22,700
| -77% | -$1.46M |
|
|
INST
1797
DELISTED
Instructure, Inc.
INST
| $453K | ﹤0.01% |
13,700
-3,800
| -22% | -$129K |
|
1798
Olin
OLN
$2.64B
| $452K | ﹤0.01% |
+12,700
| New | +$451K |
|
1799
SouthState Bank Corp
SSB
$10.3B
| $452K | ﹤0.01% |
5,188
+245
| +5% | +$22K |
|
|
TPIC
1800
DELISTED
TPI Composites
TPIC
| $452K | ﹤0.01% |
22,100
+6,000
| +37% | +$126K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.